Gastroenterology

Gastroenterology

Volume 159, Issue 4, October 2020, Pages 1592-1594.e1
Gastroenterology

Brief Communication
Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study

https://doi.org/10.1053/j.gastro.2020.06.044Get rights and content

Keywords

Anti-TNF
Adherence
Inflammatory Bowel Disease
COVID-19

Abbreviationused in this paper

IBD
inflammatory bowel disease

Cited by (0)

Conflicts of interest These authors disclose the following: Nabeel Khan has received research funding from Pfizer, Luitpold, and Takeda Pharmaceuticals. James Lewis has served as a consultant for Merck, AbbVie, Lilly, Janssen, Johnson & Johnson Consumer Inc, and Takeda; has served on Data Safety Monitoring Boards for Pfizer, Gilead, and UCB; and has received research support from Takeda and Nestle Health Science. The remaining authors disclose no conflicts.

View Abstract
© 2020 by the AGA Institute